Ulrike Hövelmann

Medicine · Health Sciences

18h-index1.2kcitations50works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(41), Diabetes Treatment and Management(34), Pancreatic function and diabetes(20), Hyperglycemia and glycemic control in critically ill and hospitalized patients(13), Pharmaceutical studies and practices(9)

Publications50 total

1773-P: Effects of the Novel Long-Acting Amylin Analogue Petrelintide on Body Weight and Waist Circumference by Sex in a Phase 1 Trial
Diabetes·2025
141-OR: Safety, Tolerability, and Clinical Effects of Dapiglutide, a Once-Weekly GLP-1R/GLP-2R Agonist
Diabetes·2025
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes
Diabetes Obesity and Metabolism·2024· 18 citedOpen Access
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
Diabetes Obesity and Metabolism·2023· 1 citedOpen Access
Author response for "Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes"
2023
Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus
Clinical Drug Investigation·2023· 30 citedOpen Access
Author response for "Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes"
2022
PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
Journal of the Endocrine Society·2022Open Access
Molecular and Biological Properties of Insulin Icodec, a New Insulin Analog Designed to Give a Long Half-Life Suitable for Once-Weekly Dosing
Diabetologie und Stoffwechsel·2022· 2 cited
A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage
Frontiers in Aging·2022· 16 citedOpen Access
Predicting True Time to Recovery From Insulin-induced Hypoglycemia With Dasiglucagon
Metabolism·2022
Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar <scp>MYL‐1601D</scp> with <scp>US</scp> and <scp>European</scp> insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study
Diabetes Obesity and Metabolism·2021· 13 citedOpen Access
Author response for "Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar MYL‐1601D with US and European insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study"
2021Open Access
344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia
Diabetes·2021
728-P: Mylan Insulin Aspart (MYL-1601D) Is Bioequivalent to Novolog (U.S.-Licensed Insulin Aspart) and NovoRapid (EU-Approved Insulin Aspart)
Diabetes·2021
345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups
Diabetes·2021
346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon
Diabetes·2021
Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial
2021· 1 citedOpen Access
Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial
2021· 2 citedOpen Access
Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial
Diabetes Care·2021· 52 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Tim Heise(24), Leona Plum‐Mörschel(16), Leszek Nosek(13), Hanne Haahr(12), Eric Zijlstra(11), Thomas R. Pieber(11), Ronnie Aronson(11), Ramin Tehranchi(8), Tadej Battelino(7), Timothy S. Bailey(7), Anita E. Melgaard(7), Linda A. DiMeglio(7), Thomas Danne(6), Lutz Heinemann(5), Daniela Lamers(5), Christoph Kapitza(5), Julie Willard(4), Simon Heller(4), Thue Johansen(4), Leslie J. Klaff(4)